Khiron Pharma ApS: Financial statements 2019
CVR: 37002984
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Khiron Pharma ApS (CVR 37002984) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -7,252 and a net result of DKK 64,014 compared with DKK 10,230 the year before. Equity in the 2019 report amounted to DKK 82,708. The solvency ratio was 67.8%.
- Gross Profit
- DKK -7,252
- Profit/Loss
- DKK 64,014
- Equity
- DKK 82,708
- Total Assets
- DKK 122,070
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -7 t. | 64 t. | 83 t. | 0 |
| 2018 | - | -8 t. | 10 t. | 19 t. | 0 |
| 2017 | - | - | 22 t. | 8 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Khiron Pharma ApS has published its annual report for 2018. Gross profit came to DKK -7,500, and the net result was DKK 10,230.
About Khiron Pharma ApS
Khiron Pharma ApS was a Danish company of the type Anpartsselskab based in Fuglebjerg, founded in 2015. The company has been dissolved on 6 December 2021. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK -6,501 and a net result of DKK -75,172 compared with DKK 64,014 the year before. Equity in the 2020 report amounted to DKK 7,536.